Naseruddin Höti

2.1k total citations
47 papers, 1.7k citations indexed

About

Naseruddin Höti is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Naseruddin Höti has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Naseruddin Höti's work include Glycosylation and Glycoproteins Research (10 papers), Advanced Proteomics Techniques and Applications (10 papers) and Prostate Cancer Treatment and Research (8 papers). Naseruddin Höti is often cited by papers focused on Glycosylation and Glycoproteins Research (10 papers), Advanced Proteomics Techniques and Applications (10 papers) and Prostate Cancer Treatment and Research (8 papers). Naseruddin Höti collaborates with scholars based in United States, China and Pakistan. Naseruddin Höti's co-authors include Hui Zhang, Mian Wu, Mark Castanares, Punit Shah, Shanshan Feng, Li Ma, Yonghui Yang, Yide Mei, Weiming Yang and Shuang Yang and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Naseruddin Höti

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naseruddin Höti United States 20 1.4k 328 319 304 194 47 1.7k
Rosa Peracaula Spain 30 1.8k 1.3× 354 1.1× 770 2.4× 402 1.3× 209 1.1× 55 2.3k
Mengjun Wang United States 20 900 0.7× 236 0.7× 259 0.8× 132 0.4× 355 1.8× 52 1.4k
Catarina Gomes Portugal 20 1.4k 1.0× 232 0.7× 610 1.9× 110 0.4× 122 0.6× 55 1.7k
Michiko Tajiri Japan 19 1.1k 0.8× 100 0.3× 251 0.8× 337 1.1× 69 0.4× 36 1.4k
Corey P. Causey United States 22 1.1k 0.8× 466 1.4× 689 2.2× 67 0.2× 342 1.8× 37 2.0k
Shifang Ren China 19 759 0.6× 137 0.4× 339 1.1× 283 0.9× 78 0.4× 59 1.2k
Katherine R. Kozak United States 24 965 0.7× 760 2.3× 342 1.1× 258 0.8× 287 1.5× 39 2.0k
Lavinia Morosi Italy 22 876 0.6× 207 0.6× 94 0.3× 284 0.9× 327 1.7× 47 1.5k
David K. Crockett United States 22 619 0.5× 171 0.5× 137 0.4× 221 0.7× 91 0.5× 49 1.2k
Luke H. Stockwin United States 18 585 0.4× 324 1.0× 183 0.6× 64 0.2× 189 1.0× 25 1.1k

Countries citing papers authored by Naseruddin Höti

Since Specialization
Citations

This map shows the geographic impact of Naseruddin Höti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naseruddin Höti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naseruddin Höti more than expected).

Fields of papers citing papers by Naseruddin Höti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naseruddin Höti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naseruddin Höti. The network helps show where Naseruddin Höti may publish in the future.

Co-authorship network of co-authors of Naseruddin Höti

This figure shows the co-authorship network connecting the top 25 collaborators of Naseruddin Höti. A scholar is included among the top collaborators of Naseruddin Höti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naseruddin Höti. Naseruddin Höti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Höti, Naseruddin, T. Mamie Lih, Mingming Dong, et al.. (2023). Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection. Cancers. 15(3). 960–960. 13 indexed citations
2.
Parveen, Sabiha, Mohd Sajid Ali, Hamad A. Al‐Lohedan, Naseruddin Höti, & Sartaj Tabassum. (2023). Molecular interaction of lysozyme with therapeutic drug azithromycin: Effect of sodium dodecyl sulfate on binding profile. International Journal of Biological Macromolecules. 242(Pt 2). 124844–124844. 6 indexed citations
3.
Song, Jin, Shiyong Ma, Lori J. Sokoll, et al.. (2021). A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer. Theranostics. 11(13). 6214–6224. 17 indexed citations
4.
Zhou, Yangying, T. Mamie Lih, Jianbo Pan, et al.. (2020). Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. Journal of Hematology & Oncology. 13(1). 170–170. 37 indexed citations
5.
Zhou, Yangying, Weiming Yang, Minghui Ao, et al.. (2020). Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL). Frontiers in Oncology. 10. 1072–1072. 9 indexed citations
6.
Dong, Mingming, T. Mamie Lih, Shao‐Yung Chen, et al.. (2020). Urinary glycoproteins associated with aggressive prostate cancer. Theranostics. 10(26). 11892–11907. 27 indexed citations
7.
Höti, Naseruddin, et al.. (2018). Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production. Cancers. 10(6). 202–202. 3 indexed citations
8.
Höti, Naseruddin, Shuang Yang, Yingwei Hu, et al.. (2018). Overexpression of α (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells. Prostate Cancer and Prostatic Diseases. 21(1). 137–146. 37 indexed citations
9.
Yang, Shuang, Naseruddin Höti, Weiming Yang, et al.. (2017). Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method. Clinical Proteomics. 14(1). 3–3. 34 indexed citations
10.
Höti, Naseruddin, Shuang Yang, Paul Aiyetan, et al.. (2017). Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer. Neoplasia. 19(10). 817–829. 9 indexed citations
11.
Sun, Shisheng, Punit Shah, Shadi Toghi Eshghi, et al.. (2015). Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides. Nature Biotechnology. 34(1). 84–88. 182 indexed citations
12.
Johnson, Timothy J., Naseruddin Höti, Chang Liu, et al.. (2013). Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer. Cancer Gene Therapy. 20(7). 394–402. 4 indexed citations
13.
Höti, Naseruddin, Wasim H. Chowdhury, Judit Ribas, et al.. (2010). Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses. Cancer Gene Therapy. 17(8). 585–597. 12 indexed citations
14.
Kachhap, Sushant K., Spencer J. Collis, Madeleine S.Q. Kortenhorst, et al.. (2010). Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor. PLoS ONE. 5(6). e11208–e11208. 134 indexed citations
15.
Höti, Naseruddin, et al.. (2008). Valproic Acid Inhibits the Growth of Cervical Cancer both In Vitro and In Vivo. The Journal of Biochemistry. 144(3). 357–362. 43 indexed citations
16.
Xia, Qinghua, Jennifer Sung, Wasim H. Chowdhury, et al.. (2006). Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo. Cancer Research. 66(14). 7237–7244. 110 indexed citations
17.
Höti, Naseruddin, Wasim H. Chowdhury, Jer‐Tsong Hsieh, et al.. (2006). Valproic Acid, a Histone Deacetylase Inhibitor, Is an Antagonist for Oncolytic Adenoviral Gene Therapy. Molecular Therapy. 14(6). 768–778. 46 indexed citations
18.
19.
20.
Ren, Bin, Naseruddin Höti, X Rabasseda, Yanan Wang, & Mian Wu. (2003). The antiangiogenic and therapeutic implications of endostatin. Methods and Findings in Experimental and Clinical Pharmacology. 25(3). 215–215. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Peracaula Breakdown of academic impact, for papers by Mengjun Wang Breakdown of academic impact, for papers by Catarina Gomes Breakdown of academic impact, for papers by Michiko Tajiri Breakdown of academic impact, for papers by Corey P. Causey Breakdown of academic impact, for papers by Shifang Ren Breakdown of academic impact, for papers by Katherine R. Kozak Breakdown of academic impact, for papers by Lavinia Morosi Breakdown of academic impact, for papers by David K. Crockett Breakdown of academic impact, for papers by Luke H. Stockwin
Rankless by CCL
2026